Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children

• Váldodahkkit: Soon Min Lee (Dahkki), Sung Jin Kim (Dahkki), Jing Chen (Dahkki), Rok Song (Dahkki), Joon-Hyung Kim (Dahkki), Raghavendra Devadiga (Dahkki), Yun-Kyung Kim (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Taylor & Francis Group, 2019-05-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Infanrix-IPV (GSK, Belgium) is a diphtheria, tetanus, acellular pertussis, and inactivated poliovirus combination vaccine (DTaP-IPV) licensed in many countries including Korea. In accordance with Korean regulations, we conducted a post-marketing surveillance (PMS) to evaluate the safety of DTaP-IPV...